---
title: Regeneron Announces Positive Phase II Results for Evinacumab
description: Regeneron Announces Positive Phase II Results for Evinacumab
---

[News ](https://www.yourway.com/news)

# [Regeneron Announces Positive Phase II Results for Evinacumab](https://www.yourway.com/news/regeneron-announces-positive-phase-ii-results-for-evinacumab)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | September 10, 2019

In a [trial](https://www.prnewswire.com/news-releases/regeneron-announces-positive-topline-results-from-phase-3-trial-of-evinacumab-in-patients-with-severe-inherited-form-of-high-cholesterol-300901035.html) evaluating patients with homozygous familial hypercholesterolemia, a genetically inherited form of increased LDL cholesterol, Regeneron’s drug showed a 49% decrease in LDL levels, compared with a 2% decrease for placebo. Yourway is dedicated to helping support clinical trials like this for rare disease patients.

[View full post](https://www.yourway.com/news/regeneron-announces-positive-phase-ii-results-for-evinacumab)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2019-09-09T17:41:06.776Z",
  "datePublished" : "2019-09-10T09:00:00Z",
  "headline" : "Regeneron Announces Positive Phase II Results for Evinacumab",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2160,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/iStock-672422186.jpg",
    "width" : 3840
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/regeneron-announces-positive-phase-ii-results-for-evinacumab",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```